levodopa has been researched along with Dysarthosis in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (8.70) | 18.7374 |
| 1990's | 4 (17.39) | 18.2507 |
| 2000's | 9 (39.13) | 29.6817 |
| 2010's | 5 (21.74) | 24.3611 |
| 2020's | 3 (13.04) | 2.80 |
| Authors | Studies |
|---|---|
| Dusek, P; Novotny, M; Rusz, J; Ruzicka, E; Sonka, K; Tykalova, T; Zogala, D | 1 |
| Honsberger, S; Husnain, MG; Su, JS | 1 |
| Altiparmak, E; Erdoğan Küçükdağli, F; Köseoğlu, HT; Öztürk, Ö; Saltoğlu, T; Sücüllü Karadağ, Y | 1 |
| Melo, A; Monteiro, L; Nóbrega, AC; Pinho, P; Soares, MFP; Tourinho, L | 1 |
| Schlegel, U; Skodda, S; Visser, W | 1 |
| Martnez-Sánchez, F | 1 |
| Grönheit, W; Schlegel, U; Skodda, S | 1 |
| Rabey, JM; Stocchi, F | 1 |
| Cavalcante, JE; Ferraz, FP; Santos, LF; Silva, DJ; Silva, LG; Sousa, JT; Souza, HA; Vilela Filho, O | 1 |
| Kleiner-Fisman, G; Lang, AE; Lozano, A; Miyasaki, J; Saint-Cyr, JA | 1 |
| Apetauerova, D; Norregaard, T; Ryan, P; Tarsy, D | 1 |
| Aguiar, PM; Behlau, MS; Ferraz, FA; Ferraz, HB; Mourão, LF | 1 |
| Benabid, AL; Fraix, V; Gentil, M; Krack, P; Pinto, S; Pollak, P; Sauleau, P | 1 |
| Barget, M; Debilly, B; Derost, PP; Durif, F; Lemaire, JJ; Llorca, PM; Morand, D; Ouchchane, L; Ulla, M | 1 |
| Boon, P; De Bodt, M; De Letter, M; Santens, P; Van Borsel, J; Van Maele, G | 1 |
| Boon, P; De Bodt, M; De Letter, M; Estercam, I; Santens, P; Van Borsel, J; Van Maele, G | 1 |
| Gawel, MJ | 1 |
| Selby, G | 1 |
| Henningson, C; Karlsson, S; Svensson, P | 1 |
| Pfeiffer, RF | 1 |
| Cahill, LM; Charles, BG; Murdoch, BE; Theodoros, DG; Triggs, EJ; Yao, AA | 1 |
| Kleinow, J; Ramig, LO; Smith, A | 1 |
| Hacki, T; Haferkamp, G; Hofmann, R; Kenklies, M | 1 |
3 review(s) available for levodopa and Dysarthosis
| Article | Year |
|---|---|
Impact of levodopa treatment in the voice pattern of Parkinson's disease patients: a systematic review and meta-analysis.
Topics: Antiparkinson Agents; Dysarthria; Dysphonia; Female; Humans; Levodopa; Male; Parkinson Disease; Speech Production Measurement; Voice; Voice Quality | 2018 |
[Speech and voice disorders in Parkinson's disease].
Topics: Antiparkinson Agents; Dysarthria; Humans; Levodopa; Parkinson Disease; Phonation; Speech Acoustics; Speech Disorders; Voice Disorders; Voice Quality | 2010 |
The effects of various drugs on speech.
Topics: Aged; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Benzodiazepines; Dysarthria; Ethanol; Female; Humans; Levodopa; Male; Middle Aged; Speech | 1981 |
1 trial(s) available for levodopa and Dysarthosis
| Article | Year |
|---|---|
Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Catechols; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Dysarthria; Facial Expression; Female; Humans; Hypokinesia; Indans; Levodopa; Male; Middle Aged; Monoamine Oxidase Inhibitors; Motor Activity; Muscle Rigidity; Nitriles; Parkinson Disease; Severity of Illness Index; Tremor | 2011 |
19 other study(ies) available for levodopa and Dysarthosis
| Article | Year |
|---|---|
Defining Speech Subtypes in De Novo Parkinson Disease: Response to Long-term Levodopa Therapy.
Topics: Dysarthria; Female; Humans; Levodopa; Parkinson Disease; Speech; Speech Disorders | 2021 |
Transient parkinsonism associated with acute Legionnaires' disease.
Topics: Adult; Anti-Bacterial Agents; Antiparkinson Agents; Carbidopa; Ciprofloxacin; Drug Combinations; Drug Therapy, Combination; Dysarthria; Humans; Legionella; Legionnaires' Disease; Levodopa; Male; Parkinsonian Disorders; Respiratory Insufficiency | 2020 |
Comprehensive assessment of levodopa-carbidopa intestinal gel for Turkish advanced Parkinson’s disease patients
Topics: Abdomen, Acute; Aged; Carbidopa; Catheterization; Deglutition Disorders; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Dysarthria; Dyskinesias; Endoscopy; Female; Gait; Gels; Humans; Intestines; Levodopa; Male; Mental Status and Dementia Tests; Middle Aged; Parkinson Disease; Quality of Life; Severity of Illness Index; Treatment Outcome; Turkey | 2021 |
Short- and long-term dopaminergic effects on dysarthria in early Parkinson's disease.
Topics: Adult; Aged; Dopamine Agents; Dysarthria; Female; Follow-Up Studies; Humans; Language Tests; Levodopa; Male; Middle Aged; Parkinson Disease; Phonetics; Reading; Severity of Illness Index; Sex Factors; Speech; Speech Production Measurement; Time Factors | 2010 |
Intonation and speech rate in Parkinson's disease: general and dynamic aspects and responsiveness to levodopa admission.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Case-Control Studies; Dysarthria; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Speech Acoustics | 2011 |
Stereotactic subthalamic nucleus lesioning for the treatment of Parkinson's disease.
Topics: Antiparkinson Agents; Combined Modality Therapy; Confusion; Dysarthria; Dyskinesias; Electric Stimulation; Electrocoagulation; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Prospective Studies; Recurrence; Safety; Severity of Illness Index; Stereotaxic Techniques; Subthalamic Nucleus; Tomography, X-Ray Computed; Treatment Outcome | 2001 |
Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up.
Topics: Confusion; Depression; Dopamine Agonists; Dysarthria; Electric Stimulation Therapy; Follow-Up Studies; Humans; Levodopa; Motor Activity; Parkinson Disease; Substance Withdrawal Syndrome; Subthalamic Nucleus; Time; Treatment Outcome | 2003 |
Adverse effects of subthalamic nucleus DBS in a patient with multiple system atrophy.
Topics: Antiparkinson Agents; Atrophy; Carbidopa; Combined Modality Therapy; Contraindications; Deglutition Disorders; Diagnosis, Differential; Dysarthria; Electric Stimulation Therapy; Electrodes, Implanted; Female; Humans; Levodopa; Magnetic Resonance Imaging; Microelectrodes; Middle Aged; Multiple System Atrophy; Parkinson Disease; Pons; Putamen; Subthalamic Nucleus | 2003 |
Acoustic voice assessment in Parkinson's disease patients submitted to posteroventral pallidotomy.
Topics: Aged; Antiparkinson Agents; Dysarthria; Female; Globus Pallidus; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Speech Acoustics; Treatment Outcome; Voice Disorders; Voice Quality | 2005 |
Changes induced by levodopa and subthalamic nucleus stimulation on parkinsonian speech.
Topics: Adult; Dysarthria; Dyskinesias; Electric Stimulation Therapy; Functional Laterality; Humans; Levodopa; Middle Aged; Parkinsonian Disorders; Severity of Illness Index; Subthalamic Nucleus | 2005 |
Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population?
Topics: Activities of Daily Living; Age Factors; Aged; Antiparkinson Agents; Bipolar Disorder; Catechols; Cognition; Combined Modality Therapy; Communication; Deep Brain Stimulation; Dysarthria; Electrodes, Implanted; Emotions; Female; Humans; Levodopa; Male; Middle Aged; Movement; Neuropsychological Tests; Nitriles; Parkinson Disease; Pergolide; Prejudice; Quality of Life; Severity of Illness Index; Subthalamic Nucleus; Treatment Outcome; Weight Gain | 2007 |
The effect of levodopa on respiration and word intelligibility in people with advanced Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Dysarthria; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Phonation; Pulmonary Ventilation; Respiratory Insufficiency; Sex Factors; Speech Intelligibility; Spirometry; Vital Capacity | 2007 |
Levodopa-induced modifications of prosody and comprehensibility in advanced Parkinson's disease as perceived by professional listeners.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Drug Therapy, Combination; Dysarthria; Female; Humans; Levodopa; Linguistics; Male; Middle Aged; Parkinson Disease; Pergolide; Sound Spectrography; Speech Acoustics; Speech Intelligibility; Speech Production Measurement; Verbal Behavior | 2007 |
The natural history of Parkinson's disease.
Topics: Activities of Daily Living; Dementia; Dysarthria; Gait; Humans; Levodopa; Movement Disorders; Muscle Rigidity; Parkinson Disease; Thalamus; Time Factors; Tremor | 1984 |
Speech motor control in Parkinson's disease: a comparison between a clinical assessment protocol and a quantitative analysis of mandibular movements.
Topics: Aged; Dysarthria; Female; Humans; Levodopa; Male; Mandible; Middle Aged; Parkinson Disease; Phonation; Verbal Behavior | 1993 |
Amantadine-induced "vocal" myoclonus.
Topics: Aged; Amantadine; Antiparkinson Agents; Carbidopa; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Dysarthria; Female; Humans; Levodopa; Myoclonus; Neurologic Examination; Parkinson Disease; Verbal Behavior | 1996 |
Effect of oral levodopa treatment on articulatory function in Parkinson's disease: preliminary results.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Antiparkinson Agents; Dose-Response Relationship, Drug; Dysarthria; Female; Humans; Levodopa; Lip; Male; Middle Aged; Parkinson Disease | 1998 |
Speech motor stability in IPD: effects of rate and loudness manipulations.
Topics: Aged; Aging; Antiparkinson Agents; Dysarthria; Female; Humans; Levodopa; Lip; Loudness Perception; Male; Mandible; Middle Aged; Parkinson Disease; Severity of Illness Index; Speech | 2001 |
[Pharmacotherapy of voice and articulation disorders in aphasia].
Topics: Aphasia; Articulation Disorders; Dysarthria; Humans; Levodopa; Speech Articulation Tests; Vocal Cords; Voice Disorders | 1990 |